magistrsko delo
Alen Pšeničnik (Author), Matej Butala (Reviewer), Hrvoje Petković (Mentor), Hrvoje Petković (Thesis defence commission member), Mojca Narat (Thesis defence commission member), Matej Butala (Thesis defence commission member)

Abstract

Streptomyces rimosus je pomemben industrijski mikroorganizem, ki proizvaja oksitetraciklin, antibiotik širokega spektra. V medicini in veterini se trenutno uporablja več polsinteznih tetraciklinksih antibiotikov. Zaradi širjenja bakterijske rezistence narašča interes po odkritju novih naravnih tetraciklinov in njihovih biosinteznih intermediatov, uporabnih za razvoj novih, bolj učinkovitih antibiotikov. Cilj tega dela je bila inaktivacija gena metiltransferaze oxyF znotraj genske gruče za biosintezo oksitetraciklina in identifikacija tarčnega produkta, 6-demetiloksitetraciklina. Konstruirali smo plazmid, ki vsebuje DNK fragment s homologijo regijam v okolici gena oxyF v genomu S. rimosus, vendar brez večjega dela gena oxyF. Na ta način konstruiran fragment DNK smo nato vstavili v »samomorilski« plazmid, imenovan pKC1139. pKC1139 vsebuje mesto za podvojevanje v E. coli in primerne gene za rezistenco na antibiotike, ki omogočajo selekcijo v E .coli in S. rimosus. Po transformaciji v S. rimosus smo uporabili dvostopenjski proces z integracijo v genom, ki ji je sledila delecija večjega dela gena oxyF, oboje preko homologne rekombinacije. Nato smo poiskali transformante S. rimosus z natančno inaktivacijo gena oxyF. Po kultivaciji smo analizirali metabolni profil izbranih kolonij z tankoplastno kromatografijo. Z uporabo masne spektrometrije smo potrdili produkcijo sicer nizkih količin 6-demetil oksitetraciklina.

Keywords

aktinomicete;Streptomyces rimosus;tetraciklini;inaktivacija gena;metiltransferaza;oksitetraciklin;

Data

Language: Slovenian
Year of publishing:
Typology: 2.09 - Master's Thesis
Organization: UL BF - Biotechnical Faculty
Publisher: [A. Pšeničnik]
UDC: 602.3:579.873.7:602.6:579.8(043.2)
COBISS: 9238905 Link will open in a new window
Views: 1548
Downloads: 3
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: English
Secondary title: Inactivation of methyltrasferase [!] oxyF gene from oxytetracycline biosynthesis gene cluster in Streptomyces rimosus bacteria
Secondary abstract: Streptomyces rimosus is an important industrial microorganism producing broad-spectrum antibiotic oxytetracycline. A number of semi-synthetic tetracyclines, are currently used in human and veterinary medicine. Due to emerging bacterial resistance, there is rising interest for new natural tetracyclines and their biosynthetic intermediates, which could be used to develop novel and more effective antibiotics . The aim of this work was to inactivate methyltransferase oxyF gene within oxytetracycline gene cluster in S. rimosus and to potentially identify target product, 6-desmethyl oxytetracycline. We consteructed a plasmid containing DNA fragment with homology to the sequence adjacent to oxyF gene from S. rimosus genome, but missing the entire oxyF gene. This way constructed DNA fragment was inserted into »suicide« plasmid designated as pKC1139, containing E. coli origin of replication and suitable resistance markers for selection in E. coli and S. rimosus. We transformed the plasmid into S.rimosus, and by applying two-stage process of chromosomal integration, followed by a double cross-over deletion, we selected for S. rimosus transformants containing precise deletion of targeted oxyF gene. We then confirmed correct double-cross over deletion of oxyF gene in a number of S. rimosus colonies. After cultivation, we analyse metabolic profile of the selected engioneered strains by thin layer chromatography. Although at low yield, we confirmed production of 6-dsemethyl oxyteracycline by mass spectroscopy.
Secondary keywords: actinomicetes;tetracyclines;gene inactivation;methyltransferase;oxytetracycline;
Type (COBISS): Master's thesis/paper
Study programme: 0
Embargo end date (OpenAIRE): 2022-06-13
Thesis comment: Univ. v Ljubljani, Biotehniška fak., Študij biotehnologije
Pages: XI, 64 f.
ID: 11159809